Related references
Note: Only part of the references are listed.Update 1 of: Recent Progress in Development of Dopamine Receptor Subtype-Selective Agents: Potential Therapeutics for Neurological and Psychiatric Disorders
Na Ye et al.
CHEMICAL REVIEWS (2013)
Regulation of GPCR activity, trafficking and localization by GPCR-interacting proteins
Ana C. Magalhaes et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
PSD-95 expression controls L-DOPA dyskinesia through dopamine D1 receptor trafficking
Gregory Porras et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
A role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental health
Jean-Martin Beaulieu
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2012)
Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents
S. Miyamoto et al.
MOLECULAR PSYCHIATRY (2012)
Modulating Neuromodulation by Receptor Membrane Traffic in the Endocytic Pathway
Mark von Zastrow et al.
NEURON (2012)
Binge Cocaine Administration in Adolescent Rats Affects Amygdalar Gene Expression Patterns and Alters Anxiety-Related Behavior in Adulthood
Stephanie E. Sillivan et al.
BIOLOGICAL PSYCHIATRY (2011)
Prefrontal cortical network connections: key site of vulnerability in stress and schizophrenia
Amy F. T. Arnsten
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2011)
Impaired Long-Term Potentiation in the Prefrontal Cortex of Huntington's Disease Mouse Models: Rescue by D-1 Dopamine Receptor Activation
G. M. Dallerac et al.
NEURODEGENERATIVE DISEASES (2011)
GSK-3 beta activity and hyperdopamine-dependent behaviors
Yan-Chun Li et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2011)
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
Jean-Martin Beaulieu et al.
PHARMACOLOGICAL REVIEWS (2011)
Functions of GSK-3 signaling in development of the nervous system
Woo-Yang Kim et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2011)
Inhibition of GSK3 attenuates dopamine D1 receptor agonist-induced hyperactivity in mice
Jonathan S. Miller et al.
BRAIN RESEARCH BULLETIN (2010)
GSK3 signalling in neural development
Eun-Mi Hur et al.
NATURE REVIEWS NEUROSCIENCE (2010)
Animal models of cognitive dysfunction and negative symptoms of schizophrenia: Focus on NMDA receptor antagonism
Joanna C. Neill et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Dopaminergic Dysfunction in Schizophrenia: Salience Attribution Revisited
Andreas Heinz et al.
SCHIZOPHRENIA BULLETIN (2010)
Akt/GSK3 Signaling in the Action of Psychotropic Drugs
Jean-Martin Beaulieu et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2009)
PSD-95 regulates D1 dopamine receptor resensitization, but not receptor-mediated Gs-protein activation
Peihua Sun et al.
CELL RESEARCH (2009)
NCS-1 in the Dentate Gyrus Promotes Exploration, Synaptic Plasticity, and Rapid Acquisition of Spatial Memory
Bechara J. Saab et al.
NEURON (2009)
The Dopamine Hypothesis of Schizophrenia: Version III - The Final Common Pathway
Oliver D. Howes et al.
SCHIZOPHRENIA BULLETIN (2009)
Evaluation of the antipsychotic effect of bi-acetylated l-stepholidine (l-SPD-A), a novel dopamine and serotonin receptor dual ligand
Yang Guo et al.
SCHIZOPHRENIA RESEARCH (2009)
Schizophrenia as a GSK-3 dysregulation disorder
Simon Lovestone et al.
TRENDS IN NEUROSCIENCES (2007)
Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions
Richard S. Jope et al.
CURRENT DRUG TARGETS (2006)
An Akt/β-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior
JM Beaulieu et al.
CELL (2005)
Transduction of receptor signals by β-arrestins
RJ Leftowitz et al.
SCIENCE (2005)
The principal features and mechanisms of dopamine modulation in the prefrontal cortex
JK Seamans et al.
PROGRESS IN NEUROBIOLOGY (2004)
Abnormalities of the NMDA receptor and associated intracellular molecules in the thalamus in schizophrenia and bipolar disorder
SM Clinton et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Regulation of dopamine D1 receptor trafficking and desensitization by oligomerization with glutamate N-methyl-D-aspartate receptors
C Fiorentini et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Glycogen synthase kinase (GSK)-3β levels and activity in a neurodevelopmental rat model of schizophrenia
C Nadri et al.
DEVELOPMENTAL BRAIN RESEARCH (2003)
Dual regulation of NMDA receptor functions by direct protein-protein interactions with the dopamine D1 receptor
FJS Lee et al.
CELL (2002)
Low GSK-3 activity in frontal cortex of schizophrenic patients
N Kozlovsky et al.
SCHIZOPHRENIA RESEARCH (2001)
Regulation of transport of the dopamine D1 receptor by a new membrane-associated ER protein
JC Bermak et al.
NATURE CELL BIOLOGY (2001)
Distinct molecular mechanisms and divergent endocytotic pathways of AMPA receptors internalization
JW Lin et al.
NATURE NEUROSCIENCE (2000)
Reversal of antipsychotic-induced working memory deficits by short-term doper D1 receptor stimulation
SA Castner et al.
SCIENCE (2000)
Low GSK-3β immunoreactivity in postmortem frontal cortex of schizophrenic patients
N Kozlovsky et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
Debating controversies can enhance creativity
SV Liu
NATURE (2000)
Share Paper
